TrialInflammation research : official journal of the European Histamine Research Society ... [et al.]2021

The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study.

Nikita V Lomakin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.